Patents Assigned to RAPTOR THERAPEUTICS INC.
  • Patent number: 8440632
    Abstract: Provided herein are ginsenoside compositions comprising at least 10% (w/w) of a protopanaxadiol type of ginsenoside suitable for administration to a subject. Also provided are methods using the ginsenoside compositions for reducing acetaldehyde concentrations, preventing or ameliorating a symptom of elevated acetaldehyde concentration, or reducing the risk of diseases or disorders caused by the intake of ethyl alcohol.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: May 14, 2013
    Assignee: Raptor Therapeutics Inc.
    Inventors: Thomas E. Daley, Michael Tempesta
  • Publication number: 20120322843
    Abstract: Provided herein are methods of administering 4-methylpyrazole (4-MP), or physiologically acceptable salts thereof, to subjects of genetic subpopulations expressing specific polymorphisms of the alcohol dehydrogenase and aldehyde dehydrogenase genes. Also provided herein are methods to prevent or ameliorate ethanol intolerance, reduce or ameliorate symptoms associated with acetaldehyde accumulation accompanying ethanol consumption, or reduce the risk of diseases or disorders caused by consumption of ethanol, comprising administering 4-MP, or physiologically acceptable salts thereof, to subjects of these subpopulations.
    Type: Application
    Filed: June 21, 2012
    Publication date: December 20, 2012
    Applicant: RAPTOR THERAPEUTICS INC.
    Inventors: Thomas E. Daley, Elizabeth C. Squiers, Kin-Hung Peony Yu